Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Director | $540K | Sep 15, 2022 | ||
ABCL | AbCellera Biologics Inc. | Director | Jun 21, 2024 | |||
BBIO | BridgeBio Pharma, Inc. | Director | Jun 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|